Renal Cancer - Results from #2740

Survival After Surgery for Renal Cell Carcinoma Metastatic to the Spine: Impact of Modern Systemic Therapies on Outcomes. June 18, 2020

Impact of the systemic immune-inflammation index for the prediction of prognosis and modification of the risk model in patients with metastatic renal cell carcinoma treated with first-line tyrosine kinase inhibitors. June 18, 2020

Safety of sunitinib in patients with renal cell carcinoma following nephrectomy. June 17, 2020

A Population Study to Identify Candidates for Cytoreductive Nephrectomy in Patients with Metastatic Sarcomatoid Renal Cell Carcinoma from the Surveillance, Epidemiology, and End Results (SEER) Database. June 17, 2020

Clinical markers of morbidity, mortality and survival in bladder cancer patients treated with radical cystectomy. A systematic review. June 17, 2020

Optimizing patient selection for cytoreductive nephrectomy based on outcomes in the contemporary era of systemic therapy. June 16, 2020

Contrast-enhanced magnetic resonance (MR) T1 mapping with low-dose gadolinium-diethylenetriamine pentaacetic acid (Gd-DTPA) is promising in identifying clear cell renal cell carcinoma histopathological grade and differentiating fat-poor angiomyolipoma. June 16, 2020

A multicenter retrospective study of nivolumab monotherapy in previously treated metastatic renal cell carcinoma patients: interim analysis of Japanese real-world data. June 15, 2020

Retroperitoneal single-site robot-assisted partial nephrectomy using Lapsingle Vision advanced access platform: initial three case reports. June 15, 2020

COVID-19 Pneumonia Mimicking Immunotherapy-Induced Pneumonitis on 18F-FDG PET/CT in a Patient Under Treatment With Nivolumab. June 15, 2020

Co-Regulation of Immune Checkpoint PD-L1 with Interferon-Gamma Signaling is Associated with a Survival Benefit in Renal Cell Cancer. June 12, 2020

DNA hypomethylation promotes transposable element expression and activation of immune signaling in renal cell cancer. June 12, 2020

Nuclear NADPH Oxidase-4 Associated With Disease Progression In Renal Cell Carcinoma. June 12, 2020

Salvage Ipilimumab and Nivolumab in Patients With Metastatic Renal Cell Carcinoma After Prior Immune Checkpoint Inhibitors. June 12, 2020

Epidemiology of Renal Cell Carcinoma. June 11, 2020

Optimal Management of First-Line Advanced Renal Cell Carcinoma: Focus on Pembrolizumab. June 11, 2020

Axitinib as a third or further line of treatment in renal cancer: a single institution experience. June 10, 2020

[Durable Response after Discontinuation Due to Immune-Related Adverse Events in a Patient with Metastatic Clear Cell Renal Cell Carcinoma : A Case Report]. June 10, 2020

Systemic therapy in metastatic renal cell carcinoma: Emerging challenges in therapeutic choice. June 9, 2020

Anti-PD-1/L1-associated immune-related adverse events as harbinger of favorable clinical outcome: systematic review and meta-analysis. June 9, 2020

Page 138 of 458